background image

Paid Clinical Trials Des Moines

Discover 270 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Des Moines IA, West Des Moines IA, Clive IA, Ankeny IAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines IA, Iowa City IA, Omaha NE, Rochester MNshow 103 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

LIVERAGEâ„¢ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting
PHASE3

Sponsor:

Boehringer Ingelheim

Location:

West Des Moines IA, Omaha NE, Columbia MO, Hammond INshow 82 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

Medication Empowerment and Deprescription for Safety (MEDS) Study

Recruiting

Sponsor:

University of Iowa

Location:

Clive IA

Code:

NCT04612166

Conditions

Aging

Fall Injury

Eligibility Criteria

Sex: All

Age: 60 - 70+

Healthy Volunteers: Not accepted

Interventions

Medication Action Plan and Patient Empowerment (MAP-PE )

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Clive IA, Columbia MO, Jefferson City MO, Conway ARshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

West Des Moines IA, Omaha NE, Coon Rapids MN, Saint Cloud MNshow 67 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyralâ„¢)

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Ames IA, Boone IA, Jefferson IA, Marshalltown IAshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting
PHASE3

Sponsor:

Children's Oncology Group

Location:

Des Moines IA, Iowa City IA, Omaha NE, Rochester MNshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines IA, Clive IA, Ankeny IA, Waukee IAshow 109 more

Code:

NCT05111574

Conditions

Anal Melanoma

Bladder Melanoma

Cervical Melanoma

Esophageal Melanoma

Gallbladder Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Recruiting
PHASE3

Sponsor:

Jaeb Center for Health Research

Location:

West Des Moines IA, Omaha NE, Rochester MN, Kansas City MOshow 54 more

Code:

NCT04378790

Conditions

Amblyopia

Eligibility Criteria

Sex: All

Age: 3 - 13

Healthy Volunteers: Not accepted

Interventions

Patching

Glasses